The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, A. H. J.
Right arrow Articles by Katsikis, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, A. H. J.
Right arrow Articles by Katsikis, P. D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2004, 173: 2524-2529.
Copyright © 2004 by The American Association of Immunologists

Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses1

Alfred H. J. Kim*, Ioannis D. Dimitriou*, M. Claire H. Holland{dagger}, Dimitrios Mastellos{dagger}, Yvonne M. Mueller*, John D. Altman{ddagger}, John D. Lambris2,{dagger} and Peter D. Katsikis2,*

* Department of Microbiology and Immunology and Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA 19129; {dagger} Protein Chemistry Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; and {ddagger} Department of Microbiology and Immunology, Emory University, Atlanta, GA 30329

The complement system has been long regarded as an important effector of the innate immune response. Furthermore, complement contributes to various aspects of B and T cell immunity. Nevertheless, the role of complement in CD8+ T cell antiviral responses has yet to be fully delineated. We examined the CD8+ T cell response in influenza type A virus-infected mice treated with a peptide antagonist to C5aR to test the potential role of complement components in CD8+ T cell responses. We show that both the frequency and absolute numbers of flu-specific CD8+ T cells are greatly reduced in C5aR antagonist-treated mice compared with untreated mice. This reduction in flu-specific CD8+ T cells is accompanied by attenuated antiviral cytolytic activity in the lungs. These results demonstrate that the binding of the C5a component of complement to the C5a receptor plays an important role in CD8+ T cell responses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Q. Peng, K. Li, N. Wang, Q. Li, E. Asgari, B. Lu, T. M. Woodruff, S. H. Sacks, and W. Zhou
Dendritic Cell Function in Allostimulation Is Modulated by C5aR Signaling
J. Immunol., November 15, 2009; 183(10): 6058 - 6068.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Nakayama, S.-I. Kim, E. H. Kim, J. D. Lambris, M. Sandor, and M. Suresh
C3 Promotes Expansion of CD8+ and CD4+ T Cells in a Listeria monocytogenes Infection
J. Immunol., September 1, 2009; 183(5): 2921 - 2931.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. M. Girgis, B. C. DeHaven, X. Fan, K. M. Viner, M. Shamim, and S. N. Isaacs
Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack
J. Virol., May 1, 2008; 82(9): 4205 - 4214.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. N. Lalli, M. G. Strainic, F. Lin, M. E. Medof, and P. S. Heeger
Decay Accelerating Factor Can Control T Cell Differentiation into IFN-{gamma}-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production
J. Immunol., November 1, 2007; 179(9): 5793 - 5802.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Fang, T. Miwa, H. Shen, and W.-C. Song
Complement-Dependent Enhancement of CD8+ T Cell Immunity to Lymphocytic Choriomeningitis Virus Infection in Decay-Accelerating Factor-Deficient Mice
J. Immunol., September 1, 2007; 179(5): 3178 - 3186.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. E. Wenderfer, B. Ke, T. J. Hollmann, R. A. Wetsel, H. Y. Lan, and M. C. Braun
C5a Receptor Deficiency Attenuates T Cell Function and Renal Disease in MRLlpr Mice
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3572 - 3582.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. S. Heeger, P. N. Lalli, F. Lin, A. Valujskikh, J. Liu, N. Muqim, Y. Xu, and M. E. Medof
Decay-accelerating factor modulates induction of T cell immunity
J. Exp. Med., May 16, 2005; 201(10): 1523 - 1530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. S. Kim and S. Perlman
Virus-Specific Antibody, in the Absence of T Cells, Mediates Demyelination in Mice Infected with a Neurotropic Coronavirus
Am. J. Pathol., March 1, 2005; 166(3): 801 - 809.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.